Canada’s new drug and biosimilar patent linkage system will fundamentally change the nature of proceedings. J Bradley White and Nathaniel Lipkus of Osler Hoskin & Harcourt discuss key changes of interest to life sciences companies
Michael Loney and Natalie Rahhal analyse five IP decisions issued in Canada, two from the Supreme Court and three from the Federal Court
The landscape for IP litigation has improved considerably in Canada. Kevin P Siu and Steven B Garland of Smart & Biggar
outline the benefits for global rights owners
RT @UPCtracker: It may be worthwhile awaiting the decision of the German Constitutional Court after all. https://t.co/EGCQe9WODb
ICYMI: easyGroup loses trade mark fight against EasyRoommate, in a judgment by Mr Justice Arnold in the England and… https://t.co/pCquiA0y7N
Analyzing Huawei’s SEP win against Samsung in Shenzhen court https://t.co/rvcrYEf0WV https://t.co/fAxIgunnXA
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2018 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International